- Conditions
- Jet Lag Type Insomnia
- Interventions
- Tasimelteon, Placebo
- Drug
- Lead sponsor
- Vanda Pharmaceuticals
- Industry
- Eligibility
- 18 Years to 75 Years
- Enrollment
- 320 participants
- Healthy volunteers
- Accepts healthy volunteers
- Timeline
- 2017 – 2018
- U.S. locations
- 12
- States / cities
- Little Rock, Arkansas • Alameda, California • San Diego, California + 9 more
Source: ClinicalTrials.gov public record
Updated Sep 14, 2023 · Synced May 22, 2026, 1:12 AM EDT